This press release was originally distributed by SBWire. Albany, NY - ( SBWIRE ) - 20/02/2019 - Antiacne Prescription Medicines Market ...
This press release was originally distributed by SBWire.
Albany, NY - ( SBWIRE ) - 20/02/2019 - Antiacne Prescription Medicines Market
Acne is a common disease that leads to the formation of lesions or pimples. The disease is characterized by an overproduction of sebum due to a high production of male hormones, called androgens, during puberty. The overactivity of the hormone causes excessive sebum production. Sebum is a greasy substance that forms in the sebaceous gland, which is just below the skin surface. Sebum is generally considered a natural moisturizer for the skin. However, excessive sebum secretion causes pimples. Acne is characterized by the formation of nodules (big papules), comedones (black and white dots), seborrhoea (red, flaky skin), scars and grains.
View of the report
https://www.transparencymarketresearch.com/prescription-antiacne-drugs-market.html
He reported that acne is a common problem among adolescents, as about 90% to 95% of males, and 83% and 85% of older teenagers are affected by 16-17 year olds. This disease tends to dissipate in average age, however, 20% of adolescents have acne, which can persist in adulthood. According to various sources estimated in 2010, about 650 million people were affected by acne. Acne has also been identified as the eighth most common disease worldwide.
It is known that acne is caused by various factors such as hormonal factors, genetic factors, psychological factors, diet and infectious agents. Acne can not be permanently cured, but acne medications are available on the market and can prevent scarring. Various drugs available for the treatment of acne include retinoids, antiandrogens, hormone treatments, benzoyl peroxide, anti-seborrhea drugs, keratolytic soaps, alpha hydroxy acid, salicylic acid, and the like. other.
Market for prescription drugs for acne: segmentation
The market for prescription medicines for acne can generally be classified according to the various medicines available on the market. Accutane (isotretinoin), Desquam-E (benzoyl peroxide), Cleocin T (clindamycin phosphate), benzamycin, erythromycin topically (A / T / S, Erycette, T-Stat), Retin-A (tretinoin) and Minocin (minocycline hydrochloride) There are several Acne medication on the market. In addition to the above medicines, tretinoin (Retin-A) is another popular remedy for acne currently available in the form of gels and creams. In addition, not all of the above medicines are prescription and can be used without a doctor's prescription without consultation with a physician. However, isotretinoin (Accutane) in capsule form is the only prescription drug. In addition, there are currently combination drugs that combine BenzaClin Clindamycin for acne with benzoyl peroxide to achieve effective acne treatment.
Request a brochure
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12266
Antiacne Prescription Market: Geographic Dynamics
The market for prescription acne medications can also be broken down geographically into North America, Europe, the Asia-Pacific region, and the rest of the world. Currently, North America holds the majority of anti-acne medicines on the world market. The area of this region has been observed due to the presence of a large number of pharmaceutical manufacturers, which means easy market penetration, high awareness of the population and an increase in the prevalence of acne. Ranbaxy Laboratories recently launched Absorica Capsules (isotretinoin) in the US market in 2012. This product is also a flagship brand in Ranbaxy's dermatology portfolio.
The Asia-Pacific region is expected to grow significantly in the future due to changes in diet and lifestyle habits, as well as greater patient awareness in the future. In addition, the growing penetration of pharmaceutical giants in the Asian region would also increase Asia's market share in the market for acne medicines. However, side effects associated with the use of acne medications are an important factor that could hinder the growth of this market.
Inquiry to the table of contents with tables and figures:
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=12266
Ranbaxy Laboratories, Roche Diagnostics, Johnson & Johnson and others are among the key players in this market.
The report provides a comprehensive assessment of the market. For this he has sound qualitative knowledge, historical data and verifiable projections of market size. The projections presented in the report are based on proven research methods and hypotheses. The research report serves as a benchmark for analysis and information on all aspects of the market, including regional markets, technologies, types and applications.
For more information about this release, visit the Web site : http://www.sbwire.com/press-releases/prescription-antiacne-drugs-market-trends-analysis-and-forecast-2016-2023-1153199 HTM
